B-SOFT(300451)2025-01-22 10:42Financial Performance Expectations - The company expects a net loss of between RMB 175 million and RMB 135 million for the fiscal year 2024, compared to a profit of RMB 36.6885 million in the same period last year [3]. - The net profit after deducting non-recurring gains and losses is projected to be a loss of between RMB 195 million and RMB 155 million, compared to a profit of RMB 33.9954 million in the previous year [3]. - The company anticipates goodwill impairment provisions of approximately RMB 90 million to RMB 130 million for 2024, based on the operating conditions and future prospects of its main subsidiaries [5]. - The financial data in this earnings forecast has not been audited, and the company will provide detailed financial information in its 2024 annual report [8]. - Investors are advised to make cautious decisions and be aware of investment risks due to the preliminary nature of the financial estimates [8]. Product Development and Innovation - The company has successfully implemented its Hi-HIS product in multiple large medical group projects across the country, enhancing its technological foundation and market confidence [6]. - The company is advancing its "HuiKang Cloud 3.0" strategy, focusing on cloud-based, integrated, intelligent, panoramic, and ecological features to improve product quality and meet user demands [6]. - The company is collaborating with Zhejiang University and Zhejiang Province's Smart Medical Innovation Center to develop AI-driven products, such as the MedCopilot and AI key patient tracking system, which have shown positive results in pilot tests [6]. Market Strategy and Operational Efficiency - The company is enhancing market expansion, innovative marketing, and new product development to improve market competitiveness and operational efficiency [7]. - The company plans to strengthen customer credit and accounts receivable management to enhance operational quality and efficiency [7].